Citigroup raises Faeth Therapeutics target price to $60 from $55
FTH•Citigroup raised its target price for Faeth Therapeutics to $60 from $55.
Related News
Canaan announces plan to implement ADS ratio change
CAN•
Fires, protests, pollution: Apple's supply chain woes in India
AAPL•
Charles Schwab files pricing term sheet for $3.00 billion of senior notes in three tranches
SCHW•
Walmart Inc.: BMO raises target price to $136 from $126
WMT•
Sixth Street Specialty Lending enters equity distribution agreement with Truist Securities
TSLX•